コンテンツへスキップ
Merck

A case of erythema multiforme developing after levetiracetam therapy.

Dermatology online journal (2013-03-12)
Yavuz Yesilova, Enver Turan, Abdurahman Sonmez, Ilyas Ozardali
要旨

Erythema multiforme is a skin disease, which occurs particularly in the acral region, and is characterized by target-like erythematous macules and papules. Infections play an important role in the etiology of erythema multiforme. Other causes include drugs, vaccination, and hematological malignancies. Half of all cases may not have an identifiable etiology. This article presents a male patient who developed erythema multiforme as a result of levetiracetam use for epilepsy.

材料
製品番号
ブランド
製品内容

Sigma-Aldrich
ピラセタム
Sigma-Aldrich
レベチラセタム, ≥98% (HPLC)
Supelco
レベチラセタム 溶液, 1.0 mg/mL in methanol, ampule of 1 mL, certified reference material, Cerilliant®
レベチラセタム, European Pharmacopoeia (EP) Reference Standard
Levetiracetam impurity D, European Pharmacopoeia (EP) Reference Standard